Melatonin Glenmark

Melatonin, the active ingredient in Melatonin Glenmark, is a melatonin receptor agonist presented as an oral formulation for oral use. It helps regulate the circadian rhythm and is used to support sleep onset in adults experiencing insomnia, jet lag, or other sleep‑onset difficulties. The product is manufactured under EU GMP guidelines and is intended for short‑term use under medical supervision.

GNH USA supplies Melatonin Glenmark as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to EU quality standards and providing reliable global distribution.

Melatonin Glenmark acts on melatonin receptors to address disorders of sleep regulation.

- Insomnia: improves sleep onset and duration in individuals with difficulty falling asleep. - Sleep onset difficulties: facilitates quicker transition to sleep in patients with delayed sleep phase. - Jet lag: helps realign circadian rhythm after rapid time‑zone travel, reducing fatigue.

Oral melatonin may be associated with a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Drowsiness: feeling unusually sleepy during the day. - Headache: mild to moderate head pain. - Dizziness: sensation of light‑headedness or unsteadiness. - Nausea: upset stomach or urge to vomit.

Serious or Rare Side Effects: - Allergic reactions: rash, swelling, or hives indicating hypersensitivity. - Mood changes: emergence of depression, anxiety, or irritability.

Before using Melatonin Glenmark, consider the following precautions.

- Pregnancy: safety not established; use only if clearly needed. - Breastfeeding: unknown; weigh potential risks against benefits. - Concomitant CNS depressants: may increase sedation. - Elderly: start with the lowest dose due to increased sensitivity. - Medical conditions: caution in patients with autoimmune disorders. - Store at ambient temperature: keep in original container, protect from moisture and light.

Melatonin Glenmark can interact with other medicines; monitor as indicated.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): may increase bleeding risk. - Immunosuppressants (e.g., cyclosporine): may reduce melatonin clearance.

Moderate Interactions (Monitor Closely): - CNS depressants (benzodiazepines, antihistamines): additive drowsiness. - Oral contraceptives: may alter melatonin metabolism. - Antidepressants (SSRIs): potential serotonin‑related effects.